×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
UCB Completes Acquisition of Zogenix, Inc.
UCB
Broadens and builds upon UCB's role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy...
1 month ago
Zogenix (ZGNX) Reports Q1 Loss, Tops Revenue Estimates
Yahoo News UK
Zogenix (ZGNX) delivered earnings and revenue surprises of -2.04% and 9.65%, respectively, for the quarter ended March 2021. Do the numbers hold clues to...
4 days ago
AACR Annual Meeting 2018 - vutrisiran, Zogenix
The Pharma Letter
The week in pharma: action, reaction and insight – week to January 21, 2022. 23-01-2022. Last week's notable announcements included Swiss pharma giant Roche...
6 days ago
How did UCB close its $1.9B deal to buy Zogenix and its key epilepsy drug? SEC filing reveals details
Fierce Pharma
On Sept. 23, 2021, UCB offered to buy Zogenix for $20.50 per share. After meeting to discuss the offer, the company informed UCB that the price...
27 months ago
FDA approves Zogenix's drug for rare childhood epilepsy
Reuters
The U.S Food and Drug Administration on Thursday approved Zogenix Inc's drug to treat seizures associated with a rare form of childhood...
10 months ago
UCB to acquire Zogenix
UCB
“We are delighted to announce UCB's proposed acquisition of Zogenix, recognizing the value of our lead medicine, both for the important role it has already...
27 months ago
UCB concludes acquisition of biopharma firm Zogenix for $1.9bn
Pharmaceutical Technology
UCB has concluded the previously announced acquisition of international biopharmaceutical firm Zogenix for up to $1.9bn (€1.7bn).
26 months ago
Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and ...
PR Newswire
"Tevard has assembled a team of leading experts focused on developing our breakthrough tRNA-based gene therapy platforms. Our collaboration with...
41 months ago
Zogenix Buys Modis in $400 Million-Plus Deal to Make Larger Rare Disease Company
BioSpace
Zogenix Buys Modis in $400 Million-Plus Deal to Make Larger Rare Disease Company ... Zogenix, based in Emeryville, California, announced it is...
56 months ago
Zogenix to submit anti-seizure drug for approval after clinical trial confirms benefit
STAT
Zogenix has confirmed the efficacy of its experimental epilepsy drug, paving the way for a marketing submission by the end of the year.
70 months ago